Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Keminterpharm Spechem Resources is an India-based private company focused on the manufacture, trading, import, and supply of specialty chemicals, especially plant growth regulators, agrochemical intermediates, and related laboratory chemicals. Publicly available company and marketplace profiles indicate that it sells products such as indole-3-butyric acid, abscisic acid, gibberellic acid, 6-benzyl adenine, emamectin benzoate, pyridoxine hydrochloride, and riboflavin. The business appears to operate as a commercial chemicals supplier rather than a drug-development biotech or pharmaceutical company. It is active, privately held, and based in Maharashtra, India, with sales and manufacturing activity centered around Mumbai/Vasai. For a biotech analyst, the key point is that this is primarily a specialty/agrochemical and intermediates business, not a therapeutic pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Keminterpharm Spechem Resources.